LifeMine Therapeutics

LifeMine Therapeutics

LifeMine Therapeutics

Discovering powerful new drugs from eukaryotic microbes by combining Genomics with AI and Synthetic Biology.
Founded
2016
Raised
$105M
Follow us
Alexa global traffic share
Latest funding
$50,000,000
Venture capital (Series B) - 2021
$55,000,000
Venture capital (Series A) - 2017
Foresite Capital ARCH Venture Partners Boyu Capital +5
Team Size
10+
Employees
$50,000,000 Venture capital (Series B)
neurons.AI

LifeMine Therapeutics Announces $50 Million Series B Financing